Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Animal Nutrition and Metabolism

Ginseng Polysaccharides Ameliorate DSS-Induced Inflammatory Bowel Disease by Regulating Gut Microbiota in Dogs

Provisionally accepted
Liuwei  XieLiuwei Xie1Xiao  LiXiao Li2Aipeng  MaoAipeng Mao3Zhiqiang  HanZhiqiang Han2Xiuli  ZhangXiuli Zhang4Xin  LiuXin Liu2Qing  LiuQing Liu1Weigang  ZhaoWeigang Zhao5*Chao  XuChao Xu2*
  • 1College of Police Dog Technology, Criminal Investigation Police University of China, Shenyang, China
  • 2College of Animal Science and Technology, College of Veterinary Medicine, Jilin Agricultural University, Changchun, China
  • 3Animal Nutrition Institute of Sichuan Agricultural University, Chengdu, China
  • 4Jilin University College of Veterinary Medicine, Changchun, China
  • 5Chinese Academy of Agricultural Sciences Institute of Special Animal and Plant Sciences, Changchun, China

The final, formatted version of the article will be published soon.

Inflammatory bowel disease (IBD) is a common chronic gastrointestinal disorder in dogs that seriously affects health and quality of life. This study evaluated the effects of ginseng polysaccharides on dextran sodium sulfate (DSS)-induced IBD in dogs, with emphasis on clinical symptoms, serum parameters, and gut microbiota. Our findings revealed that treatment with ginseng polysaccharides alleviated clinical symptoms, improved colonic histopathology, and partially restored serum biochemical changes, including a significant reduction in C-reactive protein. Microbiota analysis showed increased alpha diversity and recovery of community composition, with enrichment of beneficial genera such as Bacteroides, Megamonas, and Fusobacterium, and reduction of Campylobacter. Functional prediction indicated that ginseng polysaccharides reversed DSS-associated suppression of carbohydrate metabolism pathways. These findings suggest that ginseng polysaccharides mitigate DSS-induced IBD in dogs by modulating inflammation and gut microbiota composition, supporting their potential as a natural therapeutic candidate for canine IBD.

Keywords: Ginseng polysaccharide, Gut Microbiota, inflammatory bowel disease, Serum parameters, short-chain fatty acids

Received: 19 Sep 2025; Accepted: 15 Dec 2025.

Copyright: © 2025 Xie, Li, Mao, Han, Zhang, Liu, Liu, Zhao and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Weigang Zhao
Chao Xu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.